Fresenius SE & Co. KGaA (BIT:1FRE)
47.89
+0.66 (1.40%)
At close: Dec 4, 2025
Revenue by Geography
Fiscal year is January - December.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2013 - 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2013 - 2020 |
| North America Revenue | 2.71B | 2.70B |
Log In |
Log In |
Log In | Upgrade
|
| Europe Revenue | 16.42B | 15.66B |
Log In |
Log In |
Log In | Upgrade
|
| Asia-Pacific Revenue | 1.53B | 1.60B |
Log In |
Log In |
Log In | Upgrade
|
| Latin America Revenue | 1.37B | 1.40B |
Log In |
Log In |
Log In | Upgrade
|
| Africa Revenue | 166.00M | 156.00M |
Log In |
Log In |
Log In | Upgrade
|
Revenue
Fiscal year is January - December.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2013 - 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2013 - 2020 |
| Fresenius Kabi Revenue | 8.55B | 8.41B |
Log In |
Log In |
Log In | Upgrade
|
| Fresenius Helios Revenue | 13.28B | 12.74B |
Log In |
Log In |
Log In | Upgrade
|
| Fresenius Medical Care Revenue | - | - |
Log In |
Log In |
Log In | Upgrade
|
| Fresenius Vamed Revenue | - | - |
Log In |
Log In |
Log In | Upgrade
|
| Corporate Revenue | 382.00M | 373.00M |
Log In |
Log In |
Log In | Upgrade
|
Adjusted EBIT
Fiscal year is January - December.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2013 - 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2013 - 2020 |
| Fresenius Kabi Operating Income | 1.40B | 1.32B |
Log In |
Log In |
Log In | Upgrade
|
| Fresenius Helios Operating Income | 1.25B | 1.29B |
Log In |
Log In |
Log In | Upgrade
|
| Fresenius Medical Care Operating Income | - | - |
Log In |
Log In |
Log In | Upgrade
|
| Fresenius Vamed Operating Income | - | - |
Log In |
Log In |
Log In | Upgrade
|
| Corporate Operating Income | -127.00M | -118.00M |
Log In |
Log In |
Log In | Upgrade
|
Key Performance Indicators
Fiscal year is January - December.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2013 - 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2013 - 2020 |
| Helios Germany - Number of Hospitals | 84.00 | 85.00 |
Log In |
Log In |
Log In | Upgrade
|
| Helios Germany - Number of Beds | 29.54K | 30.03K |
Log In |
Log In |
Log In | Upgrade
|
| Helios Germany - Number of Hospital Patients | 1.20M | 1.16M |
Log In |
Log In |
Log In | Upgrade
|
| Helios Germany - Number of Outpatient Patients | 4.28M | 4.35M |
Log In |
Log In |
Log In | Upgrade
|
| Helios Germany - Total Number of Patient Admissions | 5.47M | 5.51M |
Log In |
Log In |
Log In | Upgrade
|
| Helios Spain - Number of Hospitals | 57.00 | 57.00 |
Log In |
Log In |
Log In | Upgrade
|
| Helios Spain - Number of Beds | 8.11K | 8.13K |
Log In |
Log In |
Log In | Upgrade
|
| Helios Spain - Number of Hospital Patients | 1.18M | 1.17M |
Log In |
Log In |
Log In | Upgrade
|
| Helios Spain - Number of Outpatient Patients | 20.05M | 19.67M |
Log In |
Log In |
Log In | Upgrade
|
| Helios Spain - Total Number of Patient Admissions | 21.23M | 20.84M |
Log In |
Log In |
Log In | Upgrade
|
| Fresenius Vamed - Order Intake | - | - |
Log In |
Log In |
Log In | Upgrade
|
| Fresenius Vamed - Order Backlog | - | - |
Log In |
Log In |
Log In | Upgrade
|
| Organic Revenue Growth | - | 8.00% |
Log In |
Log In |
Log In | Upgrade
|